UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant   ☒                            Filed by a party other than the Registrant  ☐

Check the appropriate box:

 

☐ Preliminary Proxy Statement

 

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

☐ Definitive Proxy Statement

 

☒ Definitive Additional Materials

 

☐ Soliciting Material Pursuant to §240.14a-12

AVEO PHARMACEUTICALS, INC.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)

Payment of Filing Fee (Check the appropriate box):

 

☒ No fee required.

 

☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  (1) Title of each class of securities to which transaction applies:

 

 

 

  (2) Aggregate number of securities to which transaction applies:

 

 

 

  (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

  (4) Proposed maximum aggregate value of transaction:

 

 

 

  (5) Total fee paid:

 

 

 

☐ Fee paid previously with preliminary materials:

 

☐ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

  (1) Amount Previously Paid:

 

 

 

  (2) Form, Schedule or Registration Statement No.:

 

 

 

  (3) Filing Party:

 

 

 

  (4) Date Filed:

 

 

 

☐ Preliminary Proxy Statement

 

 

 

*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Stockholder Meeting to Be Held on June 21, 2017

 

 

 

 

LOGO

                
          

 

Meeting Information             

 

     
           Meeting Type:   Annual Meeting      
 

    AVEO PHARMACEUTICALS, INC.

        

 

For holders as of:    April 24, 2017

     
          

 

Date:   June 21, 2017       Time:  10:00 AM EDT

     
          

 

Location:    One Broadway

     
 

 

LOGO

        

   5th Floor

   Cambridge, MA 02142

     
                  
            
LOGO         

 

You are receiving this communication because you hold shares in the above named company.

 
     

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 
     

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

 
     

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

 

 

Broadridge Internal Use Only
 
Job #
Envelope #
Sequence #
# of # Sequence #

 

   

—  Before You Vote   —

How to Access the Proxy Materials

 

     
   

Proxy Materials Available to VIEW or RECEIVE:

       
     

 

1. Notice & Proxy Statement      2. Form 10-K

 

How to View Online:

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

 

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

                                 1) BY INTERNET :          www.proxyvote.com

                                 2) BY TELEPHONE :      1-800-579-1639

                                 3) BY E-MAIL* :              sendmaterial@proxyvote.com

 

*     If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 07, 2017 to facilitate timely delivery.

 

       
           

LOGO     

 

   

 

—  How To Vote   —

Please Choose One of the Following Voting Methods

     
               
     

Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

       
     

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

       
     

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

        Internal Use   Only  
           

 

  Voting items      
 

The Board of Directors recommends you vote FOR the following:

 

         

LOGO

  1.     Election of Directors          
   

 

Nominees

         
 

 

01  Michael P. Bailey    02  Kenneth M. Bate    03  Anthony  B. Evnin    04  Henri A. Termeer    05  Robert C. Young

 
 

 

The Board of Directors recommends you vote FOR the following proposal:

         
 

 

2.

 

 

To approve a non-binding advisory vote on executive compensation.

      NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof.    
 

 

The Board of Directors recommends you vote 1 YEAR on the following proposal:

         
 

 

3.  

 

 

To hold an advisory vote on the frequency of future executive compensation advisory votes.

         
             
  The Board of Directors recommends you vote FOR proposals 4., 5., 6. and 7.          

LOGO   

 

 

 

4.  

 

 

To approve the Second Amended and Restated 2010 Stock Incentive Plan to reserve up to an additional 3,500,000 shares of common stock for issuance under the plan and to provide for certain other amendments.

         
 

 

5.  

 

 

To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of our common Stock from 200,000,000 shares to 250,000,000 shares.

         
 

 

6.  

 

 

To approve an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of our common stock, by a ratio of not less than 1-for-3 and not more than 1-for-15, such ratio and the implementation and timing of such reverse stock split to be determined in the discretion of our board of directors.

         
 

 

7.  

 

 

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2017.

     

LOGO

 

   

LOGO         

             
             
             
             
             
             
             

     

Reserved for Broadridge Internal Control Information

 

    LOGO
           
           
           
             
                  
                  
                  
    NAME          
   

THE COMPANY NAME INC. - COMMON

THE COMPANY NAME INC. - CLASS A

THE COMPANY NAME INC. - CLASS B

THE COMPANY NAME INC. - CLASS C

THE COMPANY NAME INC. - CLASS D

THE COMPANY NAME INC. - CLASS E

THE COMPANY NAME INC. - CLASS F

THE COMPANY NAME INC. - 401 K

 

123,456,789,012.12345

123,456,789,012.12345

123,456,789,012.12345

123,456,789,012.12345

123,456,789,012.12345

123,456,789,012.12345

123,456,789,012.12345

123,456,789,012.12345

     
 

 

 
 

 

 
                  
                  
                  
                  
                  
                  
                  
                  
             
        Broadridge Internal Use Only
 

 

 

THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE

  Job #
    Envelope #
    Sequence #
    # of # Sequence #

 

    

LOGO